Cyclodextrins as templates for the presentation of protease inhibitors

Schaschke N, Musiol HJ, AssfalgMachleidt I, Machleidt W, RudolphBohner S, Moroder L (1996)
FEBS LETTERS 391(3): 297-301.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ; ; ;
Erscheinungsjahr
Zeitschriftentitel
FEBS LETTERS
Band
391
Zeitschriftennummer
3
Seite
297-301
ISSN
PUB-ID

Zitieren

Schaschke N, Musiol HJ, AssfalgMachleidt I, Machleidt W, RudolphBohner S, Moroder L. Cyclodextrins as templates for the presentation of protease inhibitors. FEBS LETTERS. 1996;391(3):297-301.
Schaschke, N., Musiol, H. J., AssfalgMachleidt, I., Machleidt, W., RudolphBohner, S., & Moroder, L. (1996). Cyclodextrins as templates for the presentation of protease inhibitors. FEBS LETTERS, 391(3), 297-301. doi:10.1016/0014-5793(96)00752-1
Schaschke, N., Musiol, H. J., AssfalgMachleidt, I., Machleidt, W., RudolphBohner, S., and Moroder, L. (1996). Cyclodextrins as templates for the presentation of protease inhibitors. FEBS LETTERS 391, 297-301.
Schaschke, N., et al., 1996. Cyclodextrins as templates for the presentation of protease inhibitors. FEBS LETTERS, 391(3), p 297-301.
N. Schaschke, et al., “Cyclodextrins as templates for the presentation of protease inhibitors”, FEBS LETTERS, vol. 391, 1996, pp. 297-301.
Schaschke, N., Musiol, H.J., AssfalgMachleidt, I., Machleidt, W., RudolphBohner, S., Moroder, L.: Cyclodextrins as templates for the presentation of protease inhibitors. FEBS LETTERS. 391, 297-301 (1996).
Schaschke, Norbert, Musiol, HJ, AssfalgMachleidt, I, Machleidt, W, RudolphBohner, S, and Moroder, L. “Cyclodextrins as templates for the presentation of protease inhibitors”. FEBS LETTERS 391.3 (1996): 297-301.

8 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Carbohydrates in peptide and protein design.
Jensen KJ, Brask J., Biopolymers 80(6), 2005
PMID: 15929028
Calpastatin exon 1B-derived peptide, a selective inhibitor of calpain: enhancing cell permeability by conjugation with penetratin.
Gil-Parrado S, Assfalg-Machleidt I, Fiorino F, Deluca D, Pfeiler D, Schaschke N, Moroder L, Machleidt W., Biol Chem 384(3), 2003
PMID: 12715890
Bivalent inhibition of human beta-tryptase.
Schaschke N, Matschiner G, Zettl F, Marquardt U, Bergner A, Bode W, Sommerhoff CP, Moroder L., Chem Biol 8(4), 2001
PMID: 11325588
Synthesis of bivalent inhibitors of eucaryotic proteasomes.
Loidl G, Musiol HJ, Groll M, Huber R, Moroder L., J Pept Sci 6(1), 2000
PMID: 10674718
Beta-cyclodextrin/epoxysuccinyl peptide conjugates: a new drug targeting system for tumor cells.
Schaschke N, Assfalg-Machleidt I, Machleidt W, Lassleben T, Sommerhoff CP, Moroder L., Bioorg Med Chem Lett 10(7), 2000
PMID: 10762052
Bifunctional inhibitors of the trypsin-like activity of eukaryotic proteasomes.
Loidl G, Groll M, Musiol HJ, Ditzel L, Huber R, Moroder L., Chem Biol 6(4), 1999
PMID: 10099130
Bivalency as a principle for proteasome inhibition.
Loidl G, Groll M, Musiol HJ, Huber R, Moroder L., Proc Natl Acad Sci U S A 96(10), 1999
PMID: 10318898

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 8764993
PubMed | Europe PMC

Suchen in

Google Scholar